Helping psychedelics become approved medicines

Blossom makes information about the potential of psychedelics available to all stakeholders
to help speed up the psychedelic transition from trials to practice

We are perpetually answering the question: How do psychedelics become medicines?

Timely & Relevant

Every day, we make available the insights from psychedelic research and the companies implementing these insights. We spread this information through our weekly newsletter (The Bloom) and our partners (e.g. Lucid News).

Providing timely and relevant information will help research stay current with the field, allow companies to make discoveries more quickly, and help regulators shed outdated beliefs.

Insights ➝

Insightful & Evergreen

We back up these insights by providing an insightful and evergreen database of all things related to psychedelics as medicines. We make the troves of hidden data visible through detailed and easily searchable information on psychedelic papers, companies, key people, news, events, and more databases.

Next to the individual databases, we combine disparate psychedelic landscape pieces in detailed reports. Both resources help laypeople get a quick gain overview, help researchers see what is happening in the rest of the field, and help regulators identify where the field stands.

Database ➝ Reports ➝

Who is Blossom

Our mission is to speed up the adoption of psychedelics as a tool in therapy and self-development. We have provided these resources since 2019 that bring together different perspectives about psychedelics. We aim to be a critical, grounded in a rational and scientific worldview, yet enthusiastic voice for psychedelics.

Floris Wolswijk – Founder

Floris started Blossom to scratch his own itch. He couldn’t find a place that explained the science of psychedelics in a way that most people could understand. He was missing a place that went beyond Google Scholar searches but was not as dense as an academic book. After not finding such a resource for psychedelics (as medicine), he founded Blossom in September 2019.

Floris has a master’s degree (MSc) in Psychology (2008-2012) from the Erasmus University in Rotterdam, The Netherlands. After university, he co-founded a start-up in a different field. Through first personal experiences with psychedelics and subsequently an encounter with the scientific literature, he fell in love with the psychedelics field. He hopes to play a vital part in making psychedelics more widely available and used both in medicine and for self-development.

Simultaneously, he recognizes the utility of psychedelic-assisted coaching within the current (Dutch) framework and offers guided sessions with his wife in The Netherlands under the banner of FLO Coaching.

Roadmap ➝


Work: We have worked with the following organisations; Psychedelic Alpha (paid & volunteer (p&v)), OPEN Foundation (p&v), Lucid News (p&v), Report on Psychedelics (v), Microdose (p), Psych (p), MIND Foundation (v), Brainfutures (p), Synthesis (p), Psychedelics Today (p), Psychedelic Science Review (p), Lobe Sciences (p), and Psychedelic.Design (p&v).

Partnerships: Blossom is a promotional partner for (the events of): Horizons, MAPS, ALPS, Psychedelics Today, OPEN Foundation, MIND Foundation, Chacruna, and reMind.

Stocks: We hold no stock in any psychedelic company.